Structure Therapeutics Inc (GPCR)
41.75
+0.22
(+0.53%)
USD |
NASDAQ |
Sep 27, 16:00
41.65
-0.10
(-0.24%)
After-Hours: 20:00
Structure Therapeutics Accounts Payable (Quarterly): 2.209M for June 30, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 2.209M |
| March 31, 2024 | 6.538M |
| December 31, 2023 | 4.742M |
| September 30, 2023 | 3.319M |
| June 30, 2023 | 5.699M |
| Date | Value |
|---|---|
| March 31, 2023 | 4.945M |
| December 31, 2022 | 6.009M |
| September 30, 2022 | 5.703M |
| December 31, 2021 | 3.484M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
2.209M
Minimum
Jun 2024
6.538M
Maximum
Mar 2024
4.739M
Average
4.945M
Median
Mar 2023
Accounts Payable (Quarterly) Benchmarks
| Viking Therapeutics Inc | 11.09M |
| Eli Lilly and Co | 2.925B |
| Novo Nordisk AS | 4.272B |
| Amgen Inc | 2.267B |
| Pfizer Inc | 5.106B |